Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial-Reference-Cited by-同舟云学术

Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial

Published:2018-01-08 Issue:1 Volume:19 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Nakao Kazuhiro,Noguchi Teruo,Asaumi Yasuhide,Morita Yoshiaki,Kanaya Tomoaki,Fujino Masashi,Hosoda Hayato,Yoneda Shuichi,Kawakami Shoji,Nagai Toshiyuki,Nishihira Kensaku,Nakashima Takahiro,Kumasaka Reon,Arakawa Tetsuo,Otsuka Fumiyuki,Nakanishi Michio,Kataoka Yu,Tahara Yoshio,Goto Yoichi,Yamamoto Haruko,Hamasaki Toshimitsu,Yasuda Satoshi

Funder

Takeda Pharmaceutical Co., Ltd

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-017-2353-1.pdf

Reference28 articles.

1. Johannesson M, Jönsson B, Kjekshus J, Olsson AG, Pedersen TR, Wedel H. Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group. N Engl J Med. 1997;336(5):332–6.

2. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335(14):1001–9.

3. Group HPSC. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360(9326):7–22.